BIENAIME JEAN JACQUES

CIK 1221590
Transactions on file
24
Open-market buys
16
Win rate (buys)
75%
16 scored
Avg % since filing (buys)
+41.1%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-07-172026-07-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.6K-5.1%open →
2026-06-172026-06-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.2K-1.2%open →
2026-06-102026-06-08INCY
INCYTE CORP
Director
Grant1,642$0.00open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy1,000$19.3K+20.5%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy3,500$68.1K+19.3%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Buy6,000$116.9K+19.2%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Sale10,000$194.1K+19.6%open →
2026-06-092026-06-05IMNM
Immunome Inc.
Sale500$9.7K+19.4%open →
2026-06-052026-06-03KROS
Keros Therapeutics, Inc.
Grant7,142$0.00open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy100$22.4K+19.3%open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy200$44.5K+20.0%open →
2026-06-012026-05-29ASND
Ascendis Pharma A/S
Buy200$44.8K+19.2%open →
2026-05-282026-05-26INCY
INCYTE CORP
Director
Tax13,059$1.27M+33.8%open →
2026-05-282026-05-26INCY
INCYTE CORP
Director
Exer.15,000$1.27M+53.7%open →
2026-05-272026-05-26ASND
Ascendis Pharma A/S
Buy200$47.9K+11.4%open →
2026-05-272026-05-26ASND
Ascendis Pharma A/S
Buy200$47.2K+12.9%open →
2026-05-192026-05-15KROS
Keros Therapeutics, Inc.
Buy1,000$10.6K-4.8%open →
2026-05-192026-05-15IMNM
Immunome Inc.
Buy5,000$103.5K+12.2%open →
2026-04-172026-04-15KROS
Keros Therapeutics, Inc.
Buy1,000$11.7K-13.9%open →
2025-03-252025-03-24IMNM
Immunome Inc.
Director
Buy7,000$57.5K+182.8%open →
2025-03-262025-03-25IMNM
Immunome Inc.
Director
Buy7,800$60.7K+198.5%open →
2025-06-032025-06-03IMNM
Immunome Inc.
Director
Buy5,000$46.9K+147.5%open →
2025-06-062025-06-04KROS
Keros Therapeutics, Inc.
Director
Grant5,250$0.00open →
2025-06-122025-06-10INCY
INCYTE CORP
Director
Grant2,518$0.00open →